Letter to the Editor: In Response to Hematology...Literally and Seriously
Dr. Rosenblum responds to The Hematologist Editor-in-Chief's commentary in the Year's Best issue.
A New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD
Dr. DeBaun evaluates a new agent for the prevention of vaso-occlusive pain episodes in sickle cell disease that holds promise for first FDA approval since hydroxyurea.
Expert opinion focused on challenging diagnostic and management issues
NEW! Ask the Hematologist Compendium 2010-2015
A collection of updated clinical information on malignant and nonmalignant hematology as profiled in the "Ask the Hematologist" column of The Hematologist
Read the Compendium
Dr. Stieglitz and Dr. Koegel discuss genetic markers and risk stratification algorithms to guide individualized treatment of juvenile myelomonocytic leukemia.
Dr. Dunbar and Dr. Shaz look at indications for therapeutic plasma exchange (TPE) in the setting of thrombotic microangiopathy (TMA).
Dr. Lynch and Dr. Foucar discuss the hematopathologic diagnostic approach to treating monocytosis.
Drs. Kaufman and Liedtke discuss their management approach to patients with newly diagnosed immunoglobulin light-chain amyloidosis (AL) and cardiac involvement.
Dr. Berentsen explains his management approach to patients with primary chronic cold agglutinin disease (CAD).
Dr. George discusses her diagnostic approach to lymphocytosis.
Dr. Nakao discusses his approach to the diagnosis and treatment of immune pathophysiology in patients with low-risk myelodysplastic syndrome (MDS).
Dr. Robert J. Kreitman talks about his management approaches to treating patients with relapsed or refractory hairy cell leukemia.
Dr. Garcia discusses treatment with direct oral anticoagulants (DOACs), after the FDA approval of edoxaban, the fourth DOAC to come to the U.S. market since 2010.
Dr. Frits van Rhee and Dr. David Fajgenbaum discuss different treatment approaches to Castleman disease with the advent of anti-interleukin-6 therapy.
March-April 2017Volume 14, Issue 2
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology